脉搏波maibobo品牌怎么样 申请店铺

更新时间:2024-10-28
脉搏波maibobo是哪个国家的品牌?「脉搏波maibobo」是 深圳瑞光康泰科技有限公司 旗下著名品牌。该品牌发源于广东省深圳市,由创始人吴小光在2008-04-16期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
脉搏波maibobo怎么样

集激光技术、血压测量技术器械等的研发、生产、销售和服务为一体的高科技医疗企业,其脉搏波血压测量法在业内享有盛名


深圳瑞光康泰科技有限公司是一家专业研发、生产、销售激光技术、血压测量技术高科技企业, 拥有一支科研队伍,为产品自主研发和升级提供了强有力的技术支持。

公司自主研发的第四代血压精准测量技术——脉搏波血压测量法,现已获得中国发明专利(专利 号:ZL 2010 1 0247968.6)、日本发明专利(专利号:特许第5591404号)及韩国发明专利(专利 号:10-1460922),并在全球四十余个国家申请了发明专利。

在国内,脉搏波血压测量法已经在北京阜外医院、华中科技大学同济医学院附属协和医院等二十余家大型三甲医院通过临床验证。集团开发的“天天血压”健康管理客户端融合先进互联网技术,依托脉搏波血压计的准确数据,为顾客提供专业的血压健康管理服务。同时脉搏血压计产品已拿到注册证8个型号将近20个。规格涵盖院用、OTC、移动使用、儿童专用。

七年来,瑞光康泰不断拓展市场,在广州、北京等国内二十多个省市设立了营销网络,在国际市场,半导体激光治疗机、脉搏波血压计通过了欧盟CE认证、 出口美国、西班牙等二十多个国家和地区。


A high-tech medical enterprise integrating research and development, production, sales and service of laser technology and blood pressure measuring technology and instruments, Its pulse wave blood pressure measurement method is well-known in the industry. Shenzhen Ruiguang Kangtai Technology Co., Ltd. is a high-tech enterprise specialized in research and development, production and sales of laser technology and blood pressure measurement technology. It has a scientific research team, which provides strong technical support for independent research and development and upgrading of products. Pulse wave blood pressure measurement, the fourth generation of accurate blood pressure measurement technology independently developed by the company, has obtained Chinese invention patent (Patent No.: zl201010247968.6), Japanese invention patent (Patent No.: Chartered No.: 5591404) and Korean invention patent (Patent No.: 10-1460922), and applied for invention patent in more than 40 countries in the world. In China, the pulse wave blood pressure measurement method has passed the clinical verification in more than 20 large-scale third-class hospitals, including Beijing Fuwai Hospital, Tongji Medical College Affiliated to Huazhong University of science and technology. The "daily blood pressure" health management client developed by the group integrates advanced Internet technology and provides professional blood pressure health management services for customers based on accurate data of pulse wave sphygmomanometer. At the same time, sphygmomanometer products have been registered with 8 models and nearly 20 models. The specification covers hospital use, OTC, mobile use and children's use. In the past seven years, Ruiguang Kangtai has continuously expanded its market, established marketing networks in more than 20 provinces and cities in China, such as Guangzhou and Beijing. In the international market, semiconductor laser therapy machines and pulse wave sphygmomanometers have passed the CE certification of the European Union, exported to more than 20 countries and regions, such as the United States and Spain.

本文链接: https://brand.waitui.com/76a6090d8.html 联系电话:075526633519

千城特选小程序码

7×24h 快讯

ST板块延续强势,*ST合泰等近20股涨停

36氪获悉,截至发稿,ST板块延续强势,*ST合泰、ST东时、ST墨龙、*ST工智、*ST中迪等近20股涨停,*ST开元涨超10%。

34分钟前

光伏板块高开低走,大全能源跌超10%

36氪获悉,截至发稿,光伏板块高开低走,大全能源跌超10%,天合光能、金刚光伏、意华股份、福斯特、中信博等多股跌超5%。

34分钟前

美国麦当劳称牛肉饼非大肠杆菌污染源,将恢复下架产品

当地时间10月27日,美国麦当劳表示,经检测,汉堡中的牛肉饼不是大肠杆菌的污染源,麦当劳将于下周恢复销售此前因涉及大肠杆菌污染而暂时下架的汉堡产品,但恢复销售的汉堡将不含目前被认为是污染源的生洋葱片。(央视新闻)

34分钟前

半导体芯片股震荡走低,锴威特跌近10%

36氪获悉,截至发稿,半导体芯片股震荡走低,锴威特跌近10%,必易微跌逾7%,富乐德、台基股份、朗科科技、圣邦股份、晶华微、国民技术等跟跌。

34分钟前

辅助生殖进医保提速扩围:10月份已有多个省份公布最新进展,辅助生殖需求有望释放

10月份以来,“扩大辅助生殖技术服务资源”成为各地重要抓手。截至10月28日,本月已有广东、湖南、山西、云南、宁夏、四川、重庆等省级行政区公布辅助生殖纳入医保最新进展。其中,10月1日起,广东、湖南、山西正式将“取卵术”等相关辅助生殖类医疗服务项目统一纳入医保范围;10月15日起,宁夏将包括“取卵术”在内的10个辅助生殖类医疗服务项目和3个加收项目纳入基本医疗保险支付范围;11月份起,四川13项辅助生殖类医疗服务项目将正式纳入医保;而重庆明年1月1日起13项辅助生殖项目将纳入医保。有机构认为,随着多个省份和直辖市跟进,预示着辅助生殖需求有望快速释放,产业链发展有望提速。(证券时报)

34分钟前

本页详细列出关于脉搏波maibobo的品牌信息,含品牌所属公司介绍,脉搏波maibobo所处行业的品牌地位及优势。
咨询